Overview
In the absence of completed randomized clinical trials of surgeryversus stereotactic ablative radiotherapy, other comparative effectivenessstudies comparing both treatments in stage I non-small cell lung cancer havebeen published. These studies have occasionally reached different andconflicting conclusions. Nevertheless, population studies show a shift intreatment patterns for this patient group.
The objective of this webinar is to provide clinicians with an appreciation of the limitations of population and institutional data for comparative effectiveness studies of surgery versus stereotactic ablative radiotherapy. This one hour webinar will feature two presentations and a question/answer session.
Moderator: Professor S. Senan MRCP, FRCR, PhD
Department of Radiation Oncology,Cancer Center Amsterdam,VU University Medical Center.
Chad Rustoven, MD
Assistant Professor,University of Colorado School of Medicine,Department of Radiation Oncology.
Pamela Samson, MD, MPHS
Department of Radiation Oncology, Resident,Washington University in St. Louis.
Outcomes Data from Population Studies - Chad Rustoven, MD
Can we use retrospective institutional outcomes to inform prospective treatment allocation and shared decision making - Pamela Samson, MD
Following the presentations Suresh Senan MD, PhD, FRCR will moderate the question/answer session and lead the discussion.
For any inquiries, please contact meetings@iaslc.org.
The objective of this webinar is to provide clinicians with an appreciation of the limitations of population and institutional data for comparative effectiveness studies of surgery versus stereotactic ablative radiotherapy. This one hour webinar will feature two presentations and a question/answer session.
Moderator: Professor S. Senan MRCP, FRCR, PhD
Department of Radiation Oncology,Cancer Center Amsterdam,VU University Medical Center.
Chad Rustoven, MD
Assistant Professor,University of Colorado School of Medicine,Department of Radiation Oncology.
Pamela Samson, MD, MPHS
Department of Radiation Oncology, Resident,Washington University in St. Louis.
Outcomes Data from Population Studies - Chad Rustoven, MD
Can we use retrospective institutional outcomes to inform prospective treatment allocation and shared decision making - Pamela Samson, MD
Following the presentations Suresh Senan MD, PhD, FRCR will moderate the question/answer session and lead the discussion.
For any inquiries, please contact meetings@iaslc.org.